NC Pharmaceutical Company Gets First FDA Approval For Female Sexual Dysfunction Drug

By Frank Stasio,

Laura Lee

Published August 20, 2015 at 12:14 PM EDT

Jason deBruyn, Triangle Business Journal

The the first-ever drug for female sexual dysfunction. The Raleigh-based company, Sprout, is behind the libido pill.

This morning, Valeant Pharmaceuticals announced it is buying Sprout for $1 billion. Some hail the FDA approval as a victory for gender equality but critics say the many risky side effects outweigh the benefits.

Host Frank Stasio talks with Triangle Business Journal reporter .

Tags

Frank Stasio

Longtime NPR correspondent Frank Stasio was named permanent host of The State of Things in June 2006. A native of Buffalo, Frank has been in radio since the age of 19. He began his public radio career at WOI in Ames, Iowa, where he was a magazine show anchor and the station's 瓜神app Director.

See stories by Frank Stasio

Laura Lee

Laura Lee was the managing editor of The State of Things until mid February 2017. Born and raised in Monroe, North Carolina, Laura returned to the Old North state in 2013 after several years in Washington, DC. She received her B.A. in political science and international studies from UNC-Chapel Hill in 2002 and her J.D. from UNC-Chapel Hill School of Law in 2007.

See stories by Laura Lee